Landscape of cardiometabolic risk factors in Chinese population: a narrative review
JJ Li, HH Liu, S Li - Cardiovascular diabetology, 2022 - Springer
With rapid economic growth and changes at all levels (including environmental, social,
individual), China is facing a cardiovascular disease (CVD) crisis. In China, more than 40 …
individual), China is facing a cardiovascular disease (CVD) crisis. In China, more than 40 …
Bempedoic acid (ETC-1002): an investigational inhibitor of ATP citrate lyase
O Bilen, CM Ballantyne - Current atherosclerosis reports, 2016 - Springer
Abstract Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density
lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme …
lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme …
Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults
M Zhang, Q Deng, L Wang, Z Huang, M Zhou… - International journal of …, 2018 - Elsevier
Background Elevated serum total cholesterol and low-density lipoprotein cholesterol (LDL-
C) levels are established risk factors for cardiovascular diseases, a leading cause of death …
C) levels are established risk factors for cardiovascular diseases, a leading cause of death …
Outline of the report on cardiovascular diseases in China, 2014
C Weiwei, G Runlin, L Lisheng, Z Manlu… - European Heart …, 2016 - academic.oup.com
The risk factors for cardiovascular diseases (CVDs) are more prevalent in the Chinese
population, and therefore, increase the incidence of CVD. In general, CVD morbidity and …
population, and therefore, increase the incidence of CVD. In general, CVD morbidity and …
Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography
F Gao, ZJ Wang, XT Ma, H Shen, LX Yang… - Lipids in Health and …, 2021 - Springer
Background Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors have been
demonstrated to produce significantly greater reduction in LDL cholesterol levels and …
demonstrated to produce significantly greater reduction in LDL cholesterol levels and …
Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS)
Background Despite clear guideline recommendations, there is a paucity of data regarding
the prevalence and type of persistent lipid profile abnormalities in patients on stable lipid …
the prevalence and type of persistent lipid profile abnormalities in patients on stable lipid …
Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East
M Alshamiri, MMA Ghanaim, P Barter… - … journal of general …, 2018 - Taylor & Francis
Cardiovascular disease (CVD) is a growing burden across the world. In Asia and the Middle
East, in particular, CVD is among the most prevalent and debilitating diseases. Dyslipidemia …
East, in particular, CVD is among the most prevalent and debilitating diseases. Dyslipidemia …
Efficacy and Safety of Evolocumab in Chinese Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia: 12-Week Primary Results of the HUA TUO 华佗 …
H Tan, W Li, Z Huang, Y Han, X Huang, D Li… - Cardiology and …, 2023 - Springer
Introduction Evolocumab, a fully human proprotein convertase/subtilisin kexin type 9
inhibitor antibody, significantly lowers low-density lipoprotein cholesterol (LDL-C) in patients …
inhibitor antibody, significantly lowers low-density lipoprotein cholesterol (LDL-C) in patients …
Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea
Background It is important to achieve the low-density lipoprotein cholesterol (LDL-C) goal
recommended by clinical guidelines in managing the risk of cardiovascular (CV) events …
recommended by clinical guidelines in managing the risk of cardiovascular (CV) events …
[HTML][HTML] Knowledge, awareness, and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents
Abstract The Risk Estimation of Cardiovascular Disease (CVD) is an important factor for
predicting the incidence of cardiovascular events in a given population. This study aimed to …
predicting the incidence of cardiovascular events in a given population. This study aimed to …